Firm introduces generic antibiotic for eye infection

BALTIMORE – Lupin Pharmaceuticals Inc. has released gatifloxacin ophthalmic solution 0.5%, an antibiotic for eye infections, in the United States.

The company said Thursday that its product is the generic equivalent of Allergan Inc.’s Zymaxid Ophthalmic Solution, indicated for the treatment of bacterial conjunctivitis.

Lupin reported that it was the first applicant to file an abbreviated new drug application (ANDA) with the Food and Drug Administration for Zymaxid Ophthalmic Solution and will be entitled to 180 days of marketing exclusivity.

Read the source article at SmartBrief

About the Author

Leave a Reply